Free Trial
CVE:EQ

EQ (EQ) Stock Price, News & Analysis

EQ logo
C$0.97 0.00 (0.00%)
As of 10:35 AM Eastern

About EQ Stock (CVE:EQ)

Key Stats

Today's Range
C$0.95
C$0.97
50-Day Range
C$0.92
C$1.03
52-Week Range
C$0.86
C$1.15
Volume
7,500 shs
Average Volume
9,279 shs
Market Capitalization
C$67.51 million
P/E Ratio
N/A
Dividend Yield
0.61%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EQ and its competitors with MarketBeat's FREE daily newsletter.

EQ Stock News Headlines

Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

EQ Stock Analysis - Frequently Asked Questions

EQ's stock was trading at C$1.06 on January 1st, 2025. Since then, EQ stock has decreased by 8.5% and is now trading at C$0.97.

Shares of EQ stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that EQ investors own include Revvity (PKI), Norwegian Cruise Line (NCLH), Atara Biotherapeutics (ATRA), Denali Therapeutics (DNLI), Esperion Therapeutics (ESPR), Energy Transfer (ET) and Facedrive (FDVRF).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Advertising Agencies
Sub-Industry
Pharmaceutical Products
Current Symbol
CVE:EQ
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.66 million
Net Margins
-48.08%
Pretax Margin
N/A
Return on Equity
356.88%
Return on Assets
-18.43%

Debt

Debt-to-Equity Ratio
-105.48
Current Ratio
0.77
Quick Ratio
1.27

Sales & Book Value

Annual Sales
C$9.70 million
Price / Sales
6.96
Cash Flow
C$0.04 per share
Price / Cash Flow
23.33
Book Value
C($0.02) per share
Price / Book
-54.32

Miscellaneous

Outstanding Shares
69,594,000
Free Float
N/A
Market Cap
C$67.51 million
Optionable
Not Optionable
Beta
-0.05
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (CVE:EQ) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners